CLASS II Device recall · Reported 15 Jun 2016 · FDA Enforcement Report

FX Sodium Fluoride/Potassium Oxalate tube recalled

Greiner Bio-One North America is recalling FX Sodium Fluoride/Potassium Oxalate tube, distributed nationwide in the US. The recall was initiated on 26 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot A151137L
Quantity recalled250,800 pieces (209 cases)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1923-2016
FDA event ID
74002
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Terminated
Recall initiated
26 Apr 2016
FDA classified
7 Jun 2016
Reported
15 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

26 Apr 2016Recall initiated by company
7 Jun 2016Classified by FDA+42 days
15 Jun 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The 4 ml FX Sodium Fluoride/Potassium Oxalate tube may have no or low additive (sodium fluoride and potassium oxalate), which can effect analytical results for glucose and lactate.

Product as listed by the FDA

4 ml FX Sodium Fluoride/Potassium Oxalate tube, Ref 454297 VACUETTE Glycolytic Inhibitor Tubes contain an antiglycolytic agent, sodium fluoride, and an anticoagulant, potassium oxalate. The product is suitable for the analysis of blood glucose and lactate

Where it was distributed

Nationwide Distribution to CA, FL, IL, KY, NY, PA, VA and Puerto Rico

Nationwide CaliforniaFloridaIllinoisKentuckyNew YorkPennsylvaniaPuerto RicoVirginia

Questions about this recall

Why was it recalled?

The 4 ml FX Sodium Fluoride/Potassium Oxalate tube may have no or low additive (sodium fluoride and potassium oxalate), which can effect analytical results for glucose and lactate.

Which lots are affected?

Lot A151137L

Where was it sold?

Nationwide Distribution to CA, FL, IL, KY, NY, PA, VA and Puerto Rico

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 16

Other Insulin Pumps & Glucose Monitors recalls

All 459